A study by Indiana University School of Medicine and the Regenstrief Institute reviewed and analyzed the findings of 31 studies with a total of 120,255 participants. Each individual had a fecal immunochemical test, which identifies hidden blood in stool. FIT results were compared to the finding of a subsequent screening colonoscopy and were found to have high detection rates for colorectal cancer.
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
